• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

pH-sensitive nanoparticles reduce cancer growth by deoxygenating tumor tissue [PreClinical]

byChristine YoonandJessica Lau
January 17, 2017
in Chronic Disease, Oncology
Reading Time: 3 mins read
pH-sensitive nanoparticles reduce cancer growth by deoxygenating tumor tissue [PreClinical]
Share on FacebookShare on TwitterShare on LinkedIn

1. Under mildly acidic in vitro conditions, silicon-based nanoparticles (NPs) effectively scavenged dissolved and hemoglobin-bound oxygen (O2) and reduced breast cancer cell viability.  

2. In a mouse model of breast cancer, treatment with NPs reduced tumor tissue oxygenation and diminished tumor progression without detectable damage to vital organs.

Evidence Rating Level: 2 (Good)           

Study Rundown: Though starving tumors of O2 and nutrients has been regarded as an approach to impede rapid growth, feasible techniques to induce starvation remain elusive. In this work, oxygen-scavenging NPs were developed to deoxygenate tissues under acidic conditions and consequently block the proliferative capacity of tumors.

In vitro, mildly acidic environments activated the magnesium silicide (Mg2Si) NPs to produce reactive silane groups that acted as O2 scavenging molecules. In solutions with pH<6.5, NPs significantly reduced dissolved O2 levels to undetectable concentrations within several hours and maintained this effect for as long as 1 week. Additionally, the ability for NPs to deoxygenate solutions of oxyhemaglobin (oxyHb) was examined since most O2 is delivered in a hemoglobin-bound state. Treatment with NPs at pH 6.5 caused a significant loss of oxyHb and gain of deoxyhemaglobin (deoxyHb) whereas NPs in pH 7.4 incited no changes. In breast cancer cells exposed to NPs under acidic conditions, significant reduction in proliferation rate was accompanied with increased cell apoptosis. When tested in a mouse model of breast cancer, NP treatment significantly reduced O2 saturation levels and gross tumor growth over the course of 16 days. Importantly, NPs had undetectable negative effects on the tissue health of main organs such as the liver and lung.

This work provided promising preliminary evidence suggesting that tumor O2 starvation can be achieved through a nanotherapeutics approach. Long-term efficacy and safety must be evaluated to push this therapy into clinical use, especially since the oxygen-scavenging process generates microparticle by-products that can cause off-target organ damage.

RELATED REPORTS

FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

Click to read the study in Nature Nanotechnology 

Relevant Reading: A review of stimuli-responsive nanocarriers for drug and gene delivery

In-Depth [animal study]: Mg2Si NPs were chemically synthesized and tested for their deoxygenating capabilities in buffered solutions with pH 7.4, 6.5, and 4.5. Dissolved O2 concentrations of the solutions were measured using an O2 microelectrode every several hours and up to 7 days after NP addition. While the O2 concentration remained unchanged at pH 7.4, O2 levels of the acidic solutions became undetectable within 8 hours and remained steady for 1 week. Deoxygenation of oxyHb by NPs was examined through the addition of fresh blood collected from female BALB/c mice into solutions with pH 7.4 and 6.5. Solution samples were analyzed using UV-vis spectroscopy, which indicated a loss in absorption peaks at 542nm and 577nm (oxyHb) and a gain of a band at 555nm (deoxyHb) in the mildly acidic condition.

Proliferation studies performed on MCF-7 breast cancer cells demonstrated that 2mM NP treatment led to a nearly 50% reduction in growth relative to the control (p<0.001). At higher NP doses (5mM and 10mM), negative proliferation rates were observed, suggesting cell death. Flow cytometry confirmed that high-dose NP treatment led to nearly 3-fold and 5-fold increases in apoptotic cells, respectively.

In the mouse experiment, BALB/c mice were bilaterally injected with 4T1 breast cancer cells 10 days before treatment. Intratumoral injection of NPs (1M) triggered a significant drop in tumor blood O2 saturation over several hours whereas the saline control produced no effect. In the 16 days after treatment, tumors given saline injections rapidly grew in volume whereas tumors with NP injections remained unchanged (p<0.001, n=5 per group). At the end of treatment, histological H&E staining of vital organs (heart, spleen, lung, liver, and kidney) demonstrated negligible changes to tissue structure.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancernanotechnology
Previous Post

Review suggests use of standard rather than intensive blood pressure treatment in the elderly

Next Post

Patient and provider interventions no better than usual care for osteoarthritis

RelatedReports

An illustration depicting the colon with IV bags on either side, symbolizing sequential therapy paths in colorectal cancer treatment.
Gastroenterology

FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer

October 29, 2026
A calendar, a specimen jar, and a brush are depicted alongside a microscopic view of cervical cells, indicating cervical cancer screening.
All Specialties

An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides

October 23, 2026
An illustration featuring a stomach, DNA helix, and a close-up of Helicobacter pylori bacteria, highlighting genetic susceptibility to gastric conditions.
Artificial Intelligence

Artificial intelligence capable of identifying uncommon gastrointestinal pathologies despite no targeted disease training

October 16, 2026
A collage illustrating the urinary bladder, immune system elements, cancer cells, and an IV bag, highlighting immunotherapy for urothelial cancer.
Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026
Next Post
Reduced gestational weight gain with lifestyle intervention

Patient and provider interventions no better than usual care for osteoarthritis

Tonsillectomy may have short-term benefits in recurrent throat infection

Tonsillectomy may have short-term benefits in recurrent throat infection

Decreased prevalence of HPV among vaccinated young females

Effectiveness of meningococcal conjugate vaccine wanes after 3-8 years

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Care recommendations by large language models were associated with higher healthcare costs
  • FDA approves dostarlimab (Jemperli) for certain patients with locally advanced rectal cancer
  • In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.